Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Software defect prediction using learning to rank approach.
Nassif AB, Talib MA, Azzeh M, Alzaabi S, Khanfar R, Kharsa R, Angelis L. Nassif AB, et al. Sci Rep. 2023 Nov 2;13(1):18885. doi: 10.1038/s41598-023-45915-5. Sci Rep. 2023. PMID: 37919406 Free PMC article.
Isotretinoin-associated acne fulminans: A multicentre, retrospective study of the European Academy of Dermatology and Venereology Task Force on Acne, Rosacea and Hidradenitis Suppurativa.
Dessinioti C, Dréno B, Bettoli V, Vural S, Brzezinski P, Nassif A, Svensson Å, Zouboulis CC. Dessinioti C, et al. Among authors: nassif a. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):197-204. doi: 10.1111/jdv.19477. Epub 2023 Sep 14. J Eur Acad Dermatol Venereol. 2024. PMID: 37643921
Hidradenitis suppurativa: Impact of the French guidelines on dermatology practices.
Fottorino A, Richard MA, Prouteau C, Balland C, Villani AP, Buche S, Hotz C, Delage M, Nassif A, Cogrel O, Jouan N. Fottorino A, et al. Among authors: nassif a. Ann Dermatol Venereol. 2023 Sep;150(3):227-229. doi: 10.1016/j.annder.2022.09.008. Epub 2023 Mar 7. Ann Dermatol Venereol. 2023. PMID: 36894389 No abstract available.
Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project.
Garg A, Rawal S, Akilov O, Alavi A, Ardon C, Bechara FG, Cohen AD, Cohen SR, Daveluy S, Del Marmol V, Delage M, Esmann S, Fisher S, Giamarellos-Bourboulis EJ, Glowaczewska A, Goldfarb N, Brant EG, Grimstad Ø, Guilbault S, Hamzavi I, Hughes R, Ingram JR, Jemec GBE, Ju Q, Kappe N, Kirby B, Kirby JS, Lowes MA, Matusiak L, Micha S, Micheletti RG, Miller AP, Moseng D, Naik HB, Nassif A, Nikolakis G, Paek SY, Pascual JC, Prens E, Resnik B, Riad H, Sayed C, Smith SD, Soliman Y, Szepietowski JC, Tan J, Thorlacius L, Tzellos T, van der Zee HH, Villumsen B, Wang L, Zouboulis CC, Strunk A. Garg A, et al. Among authors: nassif a. Br J Dermatol. 2023 May 24;188(6):808-810. doi: 10.1093/bjd/ljad069. Br J Dermatol. 2023. PMID: 36891871 No abstract available.
Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
Chernyshov PV, Finlay AY, Tomas-Aragones L, Steinhoff M, Manolache L, Pustisek N, Dessinioti C, Svensson A, Marron SE, Bewley A, Salavastru C, Dréno B, Suru A, Koumaki D, Linder D, Evers AWM, Abeni D, Augustin M, Salek SS, Nassif A, Bettoli V, Szepietowski JС, Zouboulis CC. Chernyshov PV, et al. Among authors: nassif a. J Eur Acad Dermatol Venereol. 2023 May;37(5):954-964. doi: 10.1111/jdv.18918. Epub 2023 Feb 6. J Eur Acad Dermatol Venereol. 2023. PMID: 36744752
144 results